Data / Form D filings / Sethera Therapeutics, Inc
Sethera Therapeutics, Inc: Form D filing
Sethera Therapeutics, Inc, a biotechnology company in Salt Lake City, UT, filed a Form D with the SEC in 2024. The latest, on October 30, 2024, reports $1.9 million sold of a $3 million offering to 21 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 48 SOUTH RIO GRANDE STREET, Salt Lake City, UT, 84101
- Phone
- (801) 850-4367
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2024
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2042692
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 30, 2024 | New notice | $3,000,000 | $1,949,463 | $1,050,537 | 21 | Oct 15, 2024 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Vahe Bandarian | Executive Officer, Director | |
| Karsten Eastman | Executive Officer, Director | |
| Cynthia Tsai | Executive Officer, Director | |
| Yakov Kogan | Executive Officer |
Other biotechnology companies in Utah that filed recently
- Life Impact Partners 1 LLC offering · Oct 22, 2026
- 3Helix, Inc. $7.8 million · Sep 21, 2026
- Halia Therapeutics, Inc. $3.5 million · Aug 31, 2026
- Paterna BioSciences HoldCo Inc. $6.3 million · Aug 12, 2026
Every Form D from the week of Oct 28, 2024 · All recent filings in Utah · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Sethera Therapeutics, Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.